Nomination Committe for IDL appointed
IDL Biotechs extra ordinary general meeting held on the 25th October 2018 decided to establish a nomination committee.
IDL Biotech AB - provides knowledge to decision
IDL Biotech is a diagnostic company that develops, produces, and markets In Vitro Diagnostic (IVD) tests worldwide for the health care sector. We are active in the fields of oncology and bacteriology through manufacturing of various tumor markers and a rapid Salmonella typhoid test. IDL Biotech AB (publ) is a public company listed on the Swedish equities market place, Spotlight Stock Market.
German study recommends UBC® Rapid to be added in the diagnostics and follow-up of high risk bladder cancer
International Journal of Molecular Sciences has published a study on UBC® Rapid. In total 530 urine samples was included in the multicenterstudy.
Interview with Charlotte Berg
On Saturday the 17th of November, the Swedish newspaper SvD, had an interview with the CEO, Charlotte Berg.
